Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126951111 | 12695111 | 1 | I | 20160822 | 20160829 | 20160829 | EXP | CA-AMGEN-CANSP2016110459 | AMGEN | 61.00 | YR | A | F | Y | 0.00000 | 20160829 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126951111 | 12695111 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | UNK | U | 103795 | UNKNOWN FORMULATION | ||||||||
| 126951111 | 12695111 | 2 | SS | ALEVE | NAPROXEN SODIUM | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126951111 | 12695111 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126951111 | 12695111 | 4 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | UNK | 0 | ||||||||||
| 126951111 | 12695111 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | Unknown | UNK | 0 | TABLET | |||||||||
| 126951111 | 12695111 | 6 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126951111 | 12695111 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 | ||||||||||
| 126951111 | 12695111 | 8 | SS | TOCILIZUMAB | TOCILIZUMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126951111 | 12695111 | 9 | C | FOLIC ACID. | FOLIC ACID | 1 | UNK | 0 | |||||||||||
| 126951111 | 12695111 | 10 | C | HYDROXYCHLOROQUINE SULFATE. | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | |||||||||||
| 126951111 | 12695111 | 11 | C | METHOTREXATE. | METHOTREXATE | 1 | UNK | 0 | |||||||||||
| 126951111 | 12695111 | 12 | C | PLAQUENIL | HYDROXYCHLOROQUINE SULFATE | 1 | UNK | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126951111 | 12695111 | 1 | Rheumatoid arthritis |
| 126951111 | 12695111 | 2 | Rheumatoid arthritis |
| 126951111 | 12695111 | 3 | Rheumatoid arthritis |
| 126951111 | 12695111 | 4 | Rheumatoid arthritis |
| 126951111 | 12695111 | 5 | Product used for unknown indication |
| 126951111 | 12695111 | 6 | Rheumatoid arthritis |
| 126951111 | 12695111 | 7 | Product used for unknown indication |
| 126951111 | 12695111 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126951111 | 12695111 | HO |
| 126951111 | 12695111 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126951111 | 12695111 | Arthropathy | |
| 126951111 | 12695111 | C-reactive protein abnormal | |
| 126951111 | 12695111 | Fatigue | |
| 126951111 | 12695111 | Femur fracture | |
| 126951111 | 12695111 | Osteoporosis | |
| 126951111 | 12695111 | Pain | |
| 126951111 | 12695111 | Rash | |
| 126951111 | 12695111 | Red blood cell sedimentation rate abnormal | |
| 126951111 | 12695111 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |